This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jul 21;118(3):487-8.

doi: 10.1182/blood-2011-05-356568.

¿Como se llama?

Joel S Bennett¹

Affiliations

PMID: 21778348
DOI: 10.1182/blood-2011-05-356568

Free article

Comment

¿Como se llama?

Joel S Bennett. Blood. 2011.

Free article

. 2011 Jul 21;118(3):487-8.

doi: 10.1182/blood-2011-05-356568.

Author

Joel S Bennett¹

Affiliation

¹ University of Pennsylvania School of Medicine, USA.

PMID: 21778348
DOI: 10.1182/blood-2011-05-356568

No abstract available

PubMed Disclaimer

Comment on

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.
Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, Priem S, Lauwereys M, Casteels P, Van Bockstaele F, Verschueren K, Stanssens P, Baumeister J, Holz JB. Ulrichts H, et al. Blood. 2011 Jul 21;118(3):757-65. doi: 10.1182/blood-2010-11-317859. Epub 2011 May 16. Blood. 2011. PMID: 21576702

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems